Bath & Body Works, Inc. (NYSE:BBWI) Shares Sold by RWA Wealth Partners LLC

RWA Wealth Partners LLC lessened its stake in Bath & Body Works, Inc. (NYSE:BBWI) by 4.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 27,825 shares of the company’s stock after selling 1,350 shares during the quarter. RWA Wealth Partners LLC’s holdings in Bath & Body Works were worth $1,079,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Vanguard Group Inc. boosted its stake in shares of Bath & Body Works by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 28,199,787 shares of the company’s stock valued at $1,093,306,000 after purchasing an additional 208,036 shares during the period. Arrowstreet Capital Limited Partnership boosted its position in Bath & Body Works by 79.1% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 3,882,047 shares of the company’s stock valued at $150,507,000 after buying an additional 1,715,096 shares during the last quarter. FMR LLC grew its stake in shares of Bath & Body Works by 17,496.5% during the third quarter. FMR LLC now owns 2,516,127 shares of the company’s stock valued at $80,315,000 after acquiring an additional 2,501,828 shares in the last quarter. Norges Bank purchased a new stake in shares of Bath & Body Works during the fourth quarter worth about $73,572,000. Finally, Charles Schwab Investment Management Inc. increased its position in shares of Bath & Body Works by 13.0% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,704,625 shares of the company’s stock worth $66,088,000 after acquiring an additional 195,813 shares during the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Stock Performance

BBWI stock opened at $30.29 on Tuesday. The stock’s fifty day moving average is $35.08 and its two-hundred day moving average is $34.15. The stock has a market capitalization of $6.49 billion, a price-to-earnings ratio of 7.39, a PEG ratio of 0.92 and a beta of 1.89. Bath & Body Works, Inc. has a 1 year low of $26.21 and a 1 year high of $52.99.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Thursday, February 27th. The company reported $2.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.04 by $0.05. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The firm had revenue of $2.79 billion during the quarter, compared to analyst estimates of $2.78 billion. As a group, analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works declared that its Board of Directors has approved a share repurchase plan on Thursday, February 27th that allows the company to buyback $500.00 million in outstanding shares. This buyback authorization allows the company to purchase up to 6.4% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s board believes its shares are undervalued.

Bath & Body Works Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 21st were paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 2.64%. The ex-dividend date was Friday, February 21st. Bath & Body Works’s payout ratio is currently 21.98%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on BBWI shares. Barclays lowered their price objective on Bath & Body Works from $43.00 to $38.00 and set an “equal weight” rating for the company in a research note on Monday, March 3rd. TD Cowen raised their price target on shares of Bath & Body Works from $42.00 to $48.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th. Argus reaffirmed a “hold” rating on shares of Bath & Body Works in a report on Friday, January 10th. Raymond James reissued an “outperform” rating and set a $46.00 price objective (up from $42.00) on shares of Bath & Body Works in a report on Tuesday, February 25th. Finally, Robert W. Baird boosted their target price on shares of Bath & Body Works from $45.00 to $47.00 and gave the stock an “outperform” rating in a research report on Friday, February 28th. Five investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat, Bath & Body Works has an average rating of “Moderate Buy” and a consensus target price of $45.06.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.